| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory.
|
J Clin Microbiol
|
2005
|
2.89
|
|
2
|
New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci.
|
J Clin Microbiol
|
2004
|
2.64
|
|
3
|
Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.
|
Clin Infect Dis
|
2009
|
2.63
|
|
4
|
Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates.
|
Antimicrob Agents Chemother
|
2007
|
2.48
|
|
5
|
Severe bloodstream infections: a population-based assessment.
|
Crit Care Med
|
2004
|
2.39
|
|
6
|
Laboratory detection of Enterobacteriaceae that produce carbapenemases.
|
J Clin Microbiol
|
2012
|
2.24
|
|
7
|
Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel.
|
J Infect
|
2008
|
2.11
|
|
8
|
Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections.
|
J Infect Dis
|
2003
|
2.00
|
|
9
|
Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes.
|
Clin Infect Dis
|
2004
|
1.88
|
|
10
|
Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains.
|
J Infect Dis
|
2005
|
1.80
|
|
11
|
Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region.
|
J Clin Microbiol
|
2005
|
1.76
|
|
12
|
Development and validation of a molecular beacon probe-based real-time polymerase chain reaction assay for rapid detection of methicillin resistance in Staphylococcus aureus.
|
Arch Pathol Lab Med
|
2003
|
1.74
|
|
13
|
Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary.
|
Emerg Infect Dis
|
2007
|
1.56
|
|
14
|
Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases.
|
Antimicrob Agents Chemother
|
2005
|
1.49
|
|
15
|
Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology.
|
Infect Genet Evol
|
2012
|
1.48
|
|
16
|
Invasive Candida species infections: a 5 year population-based assessment.
|
J Antimicrob Chemother
|
2005
|
1.43
|
|
17
|
Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15.
|
J Clin Microbiol
|
2009
|
1.40
|
|
18
|
Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6')-Ib-cr.
|
J Antimicrob Chemother
|
2008
|
1.38
|
|
19
|
Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates.
|
J Clin Microbiol
|
2006
|
1.31
|
|
20
|
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.
|
Antimicrob Agents Chemother
|
2009
|
1.26
|
|
21
|
Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill.
|
J Crit Care
|
2002
|
1.24
|
|
22
|
Human case of lobomycosis.
|
Emerg Infect Dis
|
2004
|
1.22
|
|
23
|
Association between handling of pet treats and infection with Salmonella enterica serotype newport expressing the AmpC beta-lactamase, CMY-2.
|
J Clin Microbiol
|
2003
|
1.20
|
|
24
|
Population-based assessment of intensive care unit-acquired bloodstream infections in adults: Incidence, risk factors, and associated mortality rate.
|
Crit Care Med
|
2002
|
1.20
|
|
25
|
Compartmentalization of the gut viral reservoir in HIV-1 infected patients.
|
Retrovirology
|
2007
|
1.19
|
|
26
|
Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada.
|
Pediatr Infect Dis J
|
2008
|
1.18
|
|
27
|
The distinct category of healthcare associated bloodstream infections.
|
BMC Infect Dis
|
2012
|
1.15
|
|
28
|
Progress in the prevention of pneumococcal infection.
|
CMAJ
|
2005
|
1.14
|
|
29
|
Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistance.
|
Clin Invest Med
|
2007
|
1.14
|
|
30
|
Intensive care unit-acquired urinary tract infections in a regional critical care system.
|
Crit Care
|
2005
|
1.11
|
|
31
|
Development of a novel electronic surveillance system for monitoring of bloodstream infections.
|
Infect Control Hosp Epidemiol
|
2010
|
1.07
|
|
32
|
Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae serotypes 5 and 8 in Calgary, Canada.
|
PLoS One
|
2011
|
1.02
|
|
33
|
Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.
|
Pediatr Infect Dis J
|
2012
|
1.01
|
|
34
|
HIV-1 viral diversity and its implications for viral load testing: review of current platforms.
|
Int J Infect Dis
|
2011
|
0.99
|
|
35
|
Blood cultures in ambulatory outpatients.
|
BMC Infect Dis
|
2005
|
0.98
|
|
36
|
Population-based laboratory surveillance for Giardia sp. and Cryptosporidium sp. infections in a large Canadian health region.
|
BMC Infect Dis
|
2005
|
0.97
|
|
37
|
Comparison of direct selective versus nonselective agar media plus LIM broth enrichment for determination of group B streptococcus colonization status in pregnant women.
|
Arch Pathol Lab Med
|
2003
|
0.91
|
|
38
|
Rationale for and protocol of a multi-national population-based bacteremia surveillance collaborative.
|
BMC Res Notes
|
2009
|
0.90
|
|
39
|
Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
|
Int J Antimicrob Agents
|
2008
|
0.88
|
|
40
|
Epidemiology of Staphylococcus aureus nasal colonization and influence on outcome in the critically ill.
|
J Crit Care
|
2009
|
0.87
|
|
41
|
Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.
|
Retrovirology
|
2010
|
0.85
|
|
42
|
Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae.
|
BMC Res Notes
|
2010
|
0.85
|
|
43
|
Species-level molecular identification of invasive "Streptococcus milleri" group clinical isolates by nucleic acid sequencing in a centralized regional microbiology laboratory.
|
J Clin Microbiol
|
2005
|
0.83
|
|
44
|
Emerging gram-negative enteric infections.
|
Clin Lab Med
|
2004
|
0.82
|
|
45
|
Validation of a rapid diagnostic strategy for determination of significant bacterial counts in bronchoalveolar lavage samples.
|
Arch Pathol Lab Med
|
2005
|
0.81
|
|
46
|
A case of acute cholecystitis caused by methicillin-resistant Staphylococcus aureus in an immunocompromised patient.
|
Can J Infect Dis Med Microbiol
|
2011
|
0.80
|
|
47
|
Evaluation of a rapid bacterial ATP assay for screening BAL samples from ICU patients submitted for quantitative bacterial cultures.
|
Diagn Microbiol Infect Dis
|
2003
|
0.80
|
|
48
|
Utility of Gram stain for the microbiological analysis of burn wound surfaces.
|
Arch Pathol Lab Med
|
2003
|
0.79
|
|
49
|
Gastrointestinal viral load and enteroendocrine cell number are associated with altered survival in HIV-1 infected individuals.
|
PLoS One
|
2013
|
0.77
|
|
50
|
Antimicrobial susceptibility of invasive and lower respiratory tract isolates of Streptococcus pneumoniae, 1998 to 2007.
|
Can J Infect Dis Med Microbiol
|
2009
|
0.76
|
|
51
|
Human granulocytic anaplasmosis: First reported case in Canada.
|
Can J Infect Dis Med Microbiol
|
2009
|
0.76
|
|
52
|
Population-based laboratory surveillance of Hafnia alvei isolates in a large Canadian health region.
|
Ann Clin Microbiol Antimicrob
|
2006
|
0.75
|
|
53
|
A preliminary evaluation of the interaction between urine specific gravity and leukocyte esterase results using Bayer Multistix and the Clinitek 500.
|
Clin Biochem
|
2003
|
0.75
|
|
54
|
Selected Topics in Anaerobic Bacteriology.
|
Microbiol Spectr
|
2016
|
0.75
|